|
|
|
Volumn 49, Issue 3, 2002, Pages 578-580
|
|
In vitro activity of linezolid against Gram-positive isolated causing infection in continuous ambulatory peritoneal dialysis patients [3]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIPROFLOXACIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
GENTAMICIN;
GLYCOPEPTIDE;
LINEZOLID;
MOXIFLOXACIN;
NETILMICIN;
RIFAMPICIN;
TEICOPLANIN;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL PERITONITIS;
BACTERICIDAL ACTIVITY;
BACTERIUM ISOLATE;
CLINICAL TRIAL;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG INDICATION;
GRAM POSITIVE BACTERIUM;
HEMODIALYSIS PATIENT;
HUMAN;
IN VITRO STUDY;
LETTER;
LICENCE;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PHARMACODYNAMICS;
PHASE 1 CLINICAL TRIAL;
ACETAMIDES;
ANTI-BACTERIAL AGENTS;
GRAM-POSITIVE BACTERIA;
GRAM-POSITIVE BACTERIAL INFECTIONS;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
OXAZOLIDINONES;
PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;
|
|
EID: 0036120140
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (9)
|
|
References (6)
|
